114 related articles for article (PubMed ID: 30952517)
1. Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors.
Kim SH; Kim JW; Hwang IG; Jang JS; Hong S; Kim TY; Baek JY; Shin SH; Sun S; Hong DS; Kim HJ; Hong YS; Woo IS; Lee JH; Kim JH
J Geriatr Oncol; 2019 Sep; 10(5):749-756. PubMed ID: 30952517
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.
Hwang JE; Kim HN; Kim DE; Choi HJ; Jung SH; Shim HJ; Bae WK; Hwang EC; Cho SH; Chung IJ
BMC Cancer; 2011 Nov; 11():489. PubMed ID: 22103888
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
4. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
[TBL] [Abstract][Full Text] [Related]
5. Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
Yoo C; Kim SB; Ro J; Im SA; Im YH; Kim JH; Ahn JH; Jung KH; Song HS; Kang SY; Park HS; Chung HC
Cancer Res Treat; 2016 Apr; 48(2):499-507. PubMed ID: 26194374
[TBL] [Abstract][Full Text] [Related]
6. Serum irisin and myostatin levels after 2 weeks of high-altitude climbing.
Śliwicka E; Cisoń T; Kasprzak Z; Nowak A; Pilaczyńska-Szcześniak Ł
PLoS One; 2017; 12(7):e0181259. PubMed ID: 28732027
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer.
Tamiya M; Kobayashi M; Morimura O; Yasue T; Nakasuji T; Satomu M; Kohei O; Takayuki S; Morishita N; Suzuki H; Sasada S; Okamoto N; Hirashima T; Kawase I
Clin Lung Cancer; 2013 Jan; 14(1):50-4. PubMed ID: 22609050
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
Li ZP; Han JQ; Meng XW; Yang YF
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings.
Amano K; Maeda I; Morita T; Miura T; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Nagaoka H; Mori M; Kinoshita H
J Pain Symptom Manage; 2016 May; 51(5):860-7. PubMed ID: 26826676
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss.
Talar-Wojnarowska R; Wozniak M; Borkowska A; Olakowski M; Malecka-Panas E
J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32554845
[TBL] [Abstract][Full Text] [Related]
11. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer.
Kim DK; Oh SY; Kwon HC; Lee S; Kwon KA; Kim BG; Kim SG; Kim SH; Jang JS; Kim MC; Kim KH; Han JY; Kim HJ
BMC Cancer; 2009 May; 9():155. PubMed ID: 19457231
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic values of serum activin-a levels in patients with acute respiratory distress syndrome.
Kim JM; Lee JK; Choi SM; Lee J; Park YS; Lee CH; Yim JJ; Yoo CG; Kim YW; Han SK; Lee SM
BMC Pulm Med; 2019 Jun; 19(1):115. PubMed ID: 31238942
[TBL] [Abstract][Full Text] [Related]
13. Associations between frailty and serum N-terminal propeptide of type I procollagen and 25-hydroxyvitamin D in older Spanish women: The Toledo Study for Healthy Aging.
Alvarez-Ríos AI; Guerrero JM; García-García FJ; Rodríguez-Mañas L; Medrano-Campillo P; de la Torre Lanza MA; Alvarez-Sánchez N; Carrillo-Vico A
Exp Gerontol; 2015 Sep; 69():79-84. PubMed ID: 26031553
[TBL] [Abstract][Full Text] [Related]
14. Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
Jia Y; Li X; Zhao C; Jiang T; Zhao S; Zhang L; Liu X; Shi J; Qiao M; Luo J; Liu S; Han R; Chen X; Zhou C
Lung Cancer; 2018 Nov; 125():22-28. PubMed ID: 30429024
[TBL] [Abstract][Full Text] [Related]
15. Early increases in serum FGF21 levels predict mortality of septic patients.
Li X; Zhu Z; Zhou T; Cao X; Lu T; Liang Y; He J; Liu C; Dou Z; Shen B
Cytokine; 2018 Nov; 111():428-433. PubMed ID: 29861384
[TBL] [Abstract][Full Text] [Related]
16. Activin subfamily peptides predict chronological age in humans.
Barrios-Silva LV; Parnell M; Shinwari ZB; Chaudhary GA; Xenofontos T; van Bekhoven A; McArthur S; Elliott BT
Physiol Rep; 2018 Sep; 6(17):e13823. PubMed ID: 30178598
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.
Ilhan N; Ilhan N; Ilhan Y; Akbulut H; Kucuksu M
World J Gastroenterol; 2004 Apr; 10(8):1115-20. PubMed ID: 15069709
[TBL] [Abstract][Full Text] [Related]
18. Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib.
Cho HJ; Kim SS; Nam JS; Oh MJ; Kang DR; Kim JK; Lee JH; Kim B; Yang MJ; Hwang JC; Lim SG; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Cytokine; 2017 Jul; 95():118-125. PubMed ID: 28260649
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive value of serum C-reactive protein levels in patients with metastatic or locally recurrent gastric cancer.
Chen Z; Sun Y; Wang J; Shen X; Chen L; Zhuang Z
Int J Biol Markers; 2016 Jul; 31(3):e294-9. PubMed ID: 27174235
[TBL] [Abstract][Full Text] [Related]
20. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.
Bruhn MA; Townsend AR; Khoon Lee C; Shivasami A; Price TJ; Wrin J; Arentz G; Tebbutt NC; Hocking C; Cunningham D; Hardingham JE;
Int J Cancer; 2014 Aug; 135(3):731-41. PubMed ID: 24374727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
